Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin and oxidative stress in hemodialysis patients
IRCT138904234376N1Phase 3Completed
- Sponsor
- Mohammad Hossein Dabaghmanesh
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in end-stage kidney disease (ESKD), sponsored by Mohammad Hossein Dabaghmanesh. Started Nov 2009; status: completed.
02
Drugs
silymarin
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT138904234376N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138904234376N1.